PALB2 and hypoparathyroidism-retardation-dysmorphism syndrome: RAD51C and PALB2 deficient patients shared the BRCA2-type HRD phenotype (absence of duplications) with BRCA2 deficient patients (clusters 1–3; Fig. 3c), consistent with previous studies11,12.